Nantahala Capital Management’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $32.7K | Hold |
|
|||||
|
2023
Q2 | $23.8K | Sell |
|
|||||
|
2023
Q1 | $33.2K | Sell |
|
|||||
|
2022
Q4 | $231K | Sell |
|
|||||
|
2022
Q3 | $1.29M | Sell |
|
|||||
|
2022
Q2 | $4.91M | Buy |
|
|||||
|
2022
Q1 | $1.6M | Sell |
|
|||||
|
2021
Q4 | $2.52M | Buy |
|
|||||
|
2021
Q3 | $10M | Sell |
|
|||||
|
2021
Q2 | $11M | Sell |
|
|||||
|
2021
Q1 | $12.9M | Buy |
|
|||||
|
2020
Q4 | $11.8M | Buy |
|
|||||
|
2020
Q3 | $7.83M | Hold |
|
|||||
|
2020
Q2 | $10.7M | Buy |
|
|||||
|
2020
Q1 | $6.32M | Buy |
|
|||||
|
2019
Q4 | $7.3M | Buy |
|
|||||
|
2019
Q3 | $5.22M | Buy |
|
|||||
|
2019
Q2 | $7.69M | Buy |
|
|||||
|
2019
Q1 | $7.77M | Buy |
|
|||||
|
2018
Q4 | $6.75M | Buy |
|